Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11292765 Tryptamine prodrugs

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

April 5, 2022

Patent Application Number

17364047

Date Filed

June 30, 2021

Patent Citations Received

US Patent 12104179 Genetically modified organisms for producing psychotropic alkaloids

0

US Patent 11591353 Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

US Patent 11905535 Genetic engineering of fungi to modulate tryptamine expression

0

US Patent 12012380 Neuroplastogens and non-hallucinogenic serotonin 5-HT2A receptor modulators

0

0

US Patent 11478449 Compositions of matter and pharmaceutical compositions

US Patent 11759452 Compositions of matter and pharmaceutical compositions

Patent Primary Examiner

Rei Tsang Shiao

CPC Code

Patent abstract

The present invention provides a tryptamine prodrug compound. A compound represented by the formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11292765 Tryptamine prodrugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool